Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
DENVER, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Nexien BioPharma, Inc. ("Nexien"or the"Company") (OTCQB:NXEN), a next generation biopharmaceutical company focused on research, development and commercializ...